ALCOHOL SWABS

ALCOHOL SWABS was reported 38 times

ALCOHOL SWABS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FOSTER CARE 1 0.0909
1 CATHETER SITE DRYNESS 1 0.0256
2 PEPTOSTREPTOCOCCUS INFECTION 1 0.0095
3 APPLICATION SITE HAEMATOMA 1 0.0055
4 DEAFNESS PERMANENT 1 0.0051
5 MEIBOMIAN GLAND DYSFUNCTION 1 0.0022
6 METAPNEUMOVIRUS INFECTION 1 0.0013
7 ENDOCRINE OPHTHALMOPATHY 1 0.0012
8 RIGHT VENTRICULAR DYSFUNCTION 1 0.0009
9 STENOTROPHOMONAS INFECTION 1 0.0007
10 PARAINFLUENZAE VIRUS INFECTION 1 0.0007
11 HYPOREFLEXIA 1 0.0005
12 APPLICATION SITE SCAB 1 0.0005
13 APPLICATION SITE SWELLING 2 0.0004
14 DIABETIC COMPLICATION 1 0.0004
15 OXYGEN SATURATION ABNORMAL 1 0.0004
16 ADENOVIRUS INFECTION 1 0.0003
17 BREAST CANCER RECURRENT 1 0.0003
18 INJECTION SITE INFECTION 1 0.0003
19 PRODUCT CONTAMINATION 1 0.0003
20 CATHETER SITE INFECTION 1 0.0003
21 RHINOVIRUS INFECTION 1 0.0003
22 ABDOMINAL ABSCESS 1 0.0002
23 DERMATITIS CONTACT 2 0.0002
24 SENSITIVE SKIN 1 0.0001
25 CEREBRAL DISORDER 1 0.0001
26 PAROSMIA 1 0.0001
27 PSEUDOMONAS INFECTION 1 0.0001
28 SKIN SWELLING 1 0.0001
29 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
30 PRODUCT COMMUNICATION ISSUE 1 0.0001
31 PRODUCT DISTRIBUTION ISSUE 1 0.0001
32 RENAL PAIN 1 0.0001
33 BLOOD CALCIUM DECREASED 1 0.0001
34 SCAB 1 0.0001
35 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
36 INJECTION SITE DISCOLOURATION 1 0.0001
37 APPLICATION SITE ERYTHEMA 2 0.0001
38 ORAL CANDIDIASIS 1 0.0001
39 TOOTH INFECTION 1 0.0001
40 APPLICATION SITE RASH 1 0.0001
41 SKIN REACTION 1 0.0001
42 SINUS TACHYCARDIA 1 0.0001
43 IMPAIRED QUALITY OF LIFE 1 0.0001
44 PRODUCT USE COMPLAINT 1 0.0001
45 BACTERIAL INFECTION 1 0.0001
46 ACUTE RESPIRATORY FAILURE 1 0.0001
47 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
48 FEEDING DISORDER 1 0.0000
49 APPLICATION SITE PAIN 1 0.0000
50 NEURALGIA 1 0.0000
51 INJECTION SITE RASH 1 0.0000
52 DEVICE USE ERROR 1 0.0000
53 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
54 PRODUCT QUALITY ISSUE 3 0.0000
55 NEPHROLITHIASIS 1 0.0000
56 TINNITUS 1 0.0000
57 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
58 RENAL DISORDER 1 0.0000
59 RASH ERYTHEMATOUS 1 0.0000
60 CELLULITIS 1 0.0000
61 DRUG EFFECT DECREASED 1 0.0000
62 NECK PAIN 1 0.0000
63 ASTHMA 2 0.0000
64 VERTIGO 1 0.0000
65 DISCOMFORT 1 0.0000
66 INJECTION SITE ERYTHEMA 2 0.0000
67 DEEP VEIN THROMBOSIS 1 0.0000
68 DEVICE DIFFICULT TO USE 1 0.0000
69 INJECTION SITE REACTION 1 0.0000
70 BURNING SENSATION 1 0.0000
71 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
72 DYSGEUSIA 1 0.0000
73 DRUG DOSE OMISSION BY DEVICE 1 0.0000
74 ADVERSE EVENT 1 0.0000
75 BREAST CANCER 1 0.0000
76 SWELLING 1 0.0000
77 PULMONARY EMBOLISM 1 0.0000
78 MIGRAINE 1 0.0000
79 ILLNESS 1 0.0000
80 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
81 INFLUENZA 1 0.0000
82 MUSCULAR WEAKNESS 1 0.0000
83 PYREXIA 3 0.0000
84 BACK PAIN 2 0.0000
85 EMOTIONAL DISTRESS 1 0.0000
86 VISUAL IMPAIRMENT 1 0.0000
87 HEADACHE 5 0.0000
88 DRY SKIN 1 0.0000
89 NEUTROPENIA 1 0.0000
90 VISION BLURRED 1 0.0000
91 PRODUCT DOSE OMISSION ISSUE 2 0.0000
92 HYPOAESTHESIA 1 0.0000
93 BLOOD PRESSURE INCREASED 1 0.0000
94 INJECTION SITE PAIN 2 0.0000
95 PARAESTHESIA 1 0.0000
96 MYOCARDIAL INFARCTION 1 0.0000
97 COVID-19 1 0.0000
98 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
99 MUSCLE SPASMS 1 0.0000
100 CHEST PAIN 1 0.0000
101 PRODUCT USE ISSUE 1 0.0000
102 ANAEMIA 1 0.0000
103 PAIN 3 0.0000
104 ERYTHEMA 1 0.0000
105 DIARRHOEA 3 0.0000
106 WEIGHT INCREASED 1 0.0000
107 VOMITING 2 0.0000
108 FEELING ABNORMAL 1 0.0000
109 NAUSEA 3 0.0000
110 DYSPNOEA 2 0.0000
111 ANXIETY 1 0.0000
112 PAIN IN EXTREMITY 1 0.0000
113 PRURITUS 1 0.0000
114 ARTHRALGIA 1 0.0000
115 DEATH 2 0.0000
116 RASH 1 0.0000
117 DRUG INEFFECTIVE 2 0.0000
118 OFF LABEL USE 1 0.0000